export const posts = [
  {
    slug: 'zk-rollups-vs-optimistic-rollups',
    date: 'May 6, 2025',
    title: 'ZK Rollups vs Optimistic Rollups: A Beginner’s Guide',
    readTime: '7 min',
    tags: ['Blockchain', 'Scaling', 'Web3'],
    excerpt: 'A beginner-friendly guide to the two major rollup approaches and how they make blockchains faster, cheaper, and more scalable.',
    body: `## Table of Contents

1. Introduction
2. Why Blockchains Need Rollups
3. Optimistic Rollups: “Trust but Verify”
4. ZK Rollups: “Proof, Not Assumption”
5. Real-Life Example
6. Which Rollups Should You Care About?
7. Takeaways
8. References

## Introduction

If you’ve been exploring blockchain, you might have heard of ZK rollups and Optimistic rollups. They could sound complicated, but they’re simply just ways to make blockchains faster, cheaper, and more scalable. In this article, we’ll break down what they are, how they work, and why they matter—without assuming any prior technical knowledge.

## Why Blockchains Need Rollups

To understand rollups, you first need to understand a basic problem: scalability.

Imagine a busy highway during rush hour. Cars move slowly, traffic jams happen, and it takes a long time to reach your destination. Blockchains like Ethereum face a similar problem: as more people use the network, transactions slow down, and fees (called gas fees) go up.

Rollups are like building an express lane for blockchain transactions. Instead of all transactions happening directly on the main chain (the highway), rollups process many transactions off-chain (on the express lane), bundle them together, and then report back the final result to the main chain. This reduces congestion, saves money, and makes blockchains more scalable.

## Optimistic Rollups: “Trust but Verify”

Optimistic rollups are the simpler and older approach. They operate under one assumption: transactions are valid unless someone proves they are not.

Here’s how they work:

1. Transactions are bundled together into a batch.
2. This batch is submitted to the main blockchain.
3. There’s a challenge period, usually a week, during which anyone can dispute a transaction if they spot a mistake.
4. If a mistake is found, the batch is corrected, and the dishonest party is penalized.
5. Think of it like submitting homework online. Your teacher assumes it’s correct, but other students or teaching assistants can flag errors. Only if someone challenges a mistake does it get corrected.

### Pros of Optimistic Rollups

- Compatible with most existing smart contracts
- Easier to understand and implement
- Widely used today (e.g., Arbitrum, Optimism)

### Cons of Optimistic Rollups

- Withdrawals take longer because of the challenge period
- Slight risk if no one challenges fraudulent transactions
- Security relies on people actively checking for mistakes

## ZK Rollups: “Proof, Not Assumption”

ZK rollups, or Zero-Knowledge rollups, take a different approach. Instead of assuming transactions are correct, they cryptographically prove that transactions are valid.

Here’s how they work:

1. Transactions are bundled together off-chain.
2. A validity proof (a Zero-Knowledge proof) is generated to confirm that all transactions in the batch are correct.
3. Only the proof is submitted to the main blockchain. The main chain doesn’t need to check every single transaction—if the proof is valid, it’s accepted.

Think of it like having a trusted robot check your homework. If the robot says everything is correct, you don’t need anyone else to double-check.

### Pros of ZK Rollups

- Extremely fast and secure
- Withdrawals can happen almost instantly
- Lower risk because cryptography ensures correctness

### Cons of ZK Rollups

- More complex to build and understand
- Limited smart contract support (though this is improving with projects like zkEVMs)
- Generating proofs can require significant computational resources

## Real-Life Example

Let’s imagine you’re using a blockchain game. Every time you trade an in-game item, you’re making a transaction. On Ethereum, each transaction could take several minutes and cost a few dollars in gas fees.

Using Optimistic rollups, your transactions get bundled with others. You might have to wait a few days to withdraw assets due to the challenge period, but the system is simpler and widely supported.

Using ZK rollups, your transactions are bundled, verified with a proof, and confirmed almost instantly. You can withdraw your assets much faster, but the game developer has to ensure the system supports ZK proofs, which is more complex.

## Which Rollups Should You Care About?

If you’re just starting to learn about blockchain:

- Optimistic rollups are easier to understand and are currently the most widely used for general-purpose apps.
- ZK rollups are cutting-edge, faster, and more secure, but more complex.

Both are crucial for the future of blockchain, helping make networks scalable enough for mass adoption.

## Takeaways

Rollups are like express lanes for blockchains: they let transactions move faster and cheaper. The main difference between Optimistic and ZK rollups is how they ensure transactions are correct:

- Optimistic rollups trust and challenge if necessary.
- ZK rollups prove correctness with cryptography.

Understanding these concepts will help you make sense of the future of blockchain technology—and why scaling solutions are just as important as cryptocurrencies themselves.

## References

1. [Coinbase: What is the difference between optimistic rollups and ZK rollups](https://www.coinbase.com/learn/tips-and-tutorials/what-is-the-difference-between-optimistic-rollups-and-zk-rollups)
2. [Chainalysis: Zero-knowledge rollups vs optimistic rollups](https://www.chainalysis.com/blog/zero-knowledge-rollups-optimistic-rollups-overview/)`
  },
  {
    slug: 'securing-health-data-blockchain-hipaa',
    date: 'June 4, 2025',
    title: 'Securing Health Data: Blockchain and HIPAA Compliance',
    readTime: '9 min',
    tags: ['Healthcare', 'Blockchain', 'Privacy'],
    excerpt: 'How blockchain-based audit trails and hybrid storage models could support more secure, interoperable health data systems.',
    body: `## Table of Contents

1. Introduction
2. Key Terms
3. What is HIPAA?
4. How Blockchain Aligns with HIPAA
5. Use Cases: Blockchain in Healthcare
6. Challenges and Considerations
7. A Path Forward
8. References

## Introduction

Health data is deeply sensitive. HIPAA (Health Insurance Portability and Accountability Act) governs the privacy and security of patient information in the U.S. Passed in 1996, it established strict standards for healthcare providers, insurers, and their business associates to ensure that Protected Health Information (PHI) remain confidential and tamper-proof. Despite decades of regulation, data breaches and the total number of exposed records have significantly increased in recent years. Many health systems struggle with data silos, lack of interoperability, and opaque consent management. Ransomware, insufficient access controls, weak authentication, and lack of data encryption leave patient data vulnerable and easy to hack into.

**Blockchain’s secure, decentralized, and auditable architecture** offers a promising framework to **enhance patient control and data integrity.**

## Key Terms

To understand this article, the following terms are helpful to know:

- **PHI (Protected Health Information):** Any health data linked to an individual. This includes data about a person’s health status, healthcare provision, and payment for healthcare, as these details can identify the individual’s name, address, birth date, SSN, and medical record number.
- **EHR (Electronic Health Record):** Digital version of a patient’s medical history maintained by healthcare providers.
- **Smart Contract:** Self-executing code stored on a blockchain that enforces rules automatically.

## What is HIPAA?

HIPAA sets national standards for safeguarding medical data. It establishes:

### Privacy Rule

- Applies to healthcare providers, insurers, and businesses (vendors and contractors) to limit access to and use of PHI
- Outlines potential criminal charges if someone knowingly discloses PHI. These penalties range from $100 to $50,000 per violation up to $1.5 million per year for identical provisions.

### Security Rule

- Mandates safeguards to ensure confidentiality, integrity, and availability of electronic PHI

### Breach Notification Rule

- Requires disclosure of data breaches

While HIPAA regulates data protection and digital security standards, it does not outline specific interactions and integration of technology. This lack of scope leaves enforcement mechanisms vague and open, making it easy for inexperienced cybersecurity teams to inadvertently create many openings for malicious parties.

In 2023, there were 725 breaches reported by the HIPAA journal, involving 133 million exposed records. By 2025, the HIPAA journal revised this figure to 276 million instead. Just in January of this year, a massive ransomware-led cyberattack on Change Healthcare leaked the sensitive information of around 190 million patients, followed by 2.7 million more in the DaVita ransomware attack in April. The present vulnerability of our legacy systems underscores the need for innovative products to emerge in order to provide cryptographic guarantees and transparent audit trails.

## How Blockchain Aligns with HIPAA

The healthcare industry loses billions annually due to fraud, inefficiencies, and data breaches. Blockchain offers transparency for patients and providers, security against tampering, and efficiency in cross-institutional data sharing.

### Immutability

- Blockchain ensures that once medical data is logged, it cannot be altered retroactively. This strengthens auditability for HIPAA compliance.

### Patient-controlled access

- With public and private keys, patients can grant or revoke access to their health records in real time, aligning with HIPAA’s principles of informed consent.

### Decentralized verification

- Distributed ledgers reduce reliance on a single central entity. Verification by multiple nodes creates resilience against data tampering and insider threats.

### Hybrid models

- PHI cannot be stored directly on-chain (due to immutability conflicts with HIPAA’s right-to-amend rules). Instead, off-chain storage combined with on-chain hashes offers a balance between verifiability and compliance. Off-chain storage can ensure that sensitive PHI is encrypted and stored in secure databases or cloud providers. On-chain references can strengthen integrity without exposing raw data by storing cryptographic hashes of the PHI on the blockchain. Smart contracts can help control permissions and track amendments by updating the on-chain hash reference when PHI is updated off-chain. This design ensures compliance with HIPAA’s “right to amend” while maintaining blockchain’s benefits of auditability and tamper detection.

Blockchain’s properties align under HIPAA’s “Covered Entity requirements” seamlessly:

## Use Cases: Blockchain in Healthcare

### Electronic Health Records (EHR) interoperability

- Providers across different institutions can securely exchange PHI while patients retain full control.

### Consent Management

- Smart contracts can encode and enforce who can view, edit, or share data

### Research Data Sharing

- Patients may choose to consent to anonymized health data for research, with transparent opt-in/opt-out mechanisms.

### Medical Supply Chain Tracking

- Beyond PHI, blockchain can verify the integrity and origin of pharmaceuticals, reducing counterfeit risks.

## Challenges and Considerations

### Immutability vs Right to Amend

- HIPAA requires that patients be able to correct their health records. Pure on-chain storage conflicts with this mandate, requiring creative hybrid approaches.

### Key Management

- If patients lose their private keys, they risk losing access to their PHI. Key recovery mechanisms are a critical design hurdle.

### Scalability and Cost

- Storing large imaging files or genomic data directly on-chain is infeasible. On-chain solutions are essential.

### Adoption & Interoperability

- Healthcare IT infrastructure is fragmented. Blockchain solutions must integrate seamlessly with legacy EHR systems to see widespread adoption.

## A Path Forward

HIPAA compliance is non-negotiable in healthcare, but the current infrastructure is outdated and prone to breaches. Blockchain offers an opportunity to modernize health data management while balancing privacy, transparency, and efficiency. HIPAA cannot be replaced by blockchain, but blockchain’s strengths can be leveraged to meet HIPAA’s strict mandates more securely. Hybrid blockchain models can be designed to honor patients’ rights while ensuring regulatory compliance.

## References

1. [HIPAA Vault: Blockchain and HIPAA compliance](https://www.hipaavault.com/resources/hipaa-compliant-hosting-insights/blockchain-hipaa-compliance)
2. [Paubox: The role of blockchain in healthcare audits](https://www.paubox.com/blog/the-role-of-blockchain-in-healthcare-audits)
3. [Compliancy Group: HIPAA-compliant blockchain in healthcare](https://compliancy-group.com/hipaa-compliant-blockchain-healthcare)
4. [Investopedia: How health care is moving toward blockchain](https://www.investopedia.com/tech/how-health-care-moving-toward-blockchain)
5. [Censinet: Emerging blockchain privacy standards in digital health](https://www.censinet.com/perspectives/emerging-blockchain-privacy-standards-in-digital-health)
6. [PubMed Central: Article on blockchain and healthcare](https://pmc.ncbi.nlm.nih.gov/articles/PMC11082361)`
  },
  {
    slug: 'case-study-mediledger-blockchain',
    date: 'Jul 3, 2025',
    title: "Case Study: MediLedger's Use of Blockchain",
    readTime: '12 min',
    tags: ['Healthcare', 'Blockchain', 'Supply Chain'],
    excerpt: 'How a permissioned blockchain network approached pharmaceutical traceability, drug-return verification, privacy, and interoperability across a complex supply chain.',
    body: `## Table of Contents

1. Introduction
2. MediLedger’s Use of Blockchain
3. The Legacy
4. Key Players
5. Summary of Outcomes
6. Architecture at a Glance
7. What Worked Well
8. Challenges Observed
9. Takeaways
10. Things to Think About

## Introduction

The U.S. pharmaceutical supply chain moves over 4 billion prescription medicines annually through a network of manufacturers, wholesalers, and pharmacies. From an industrial engineering perspective, this system is a massive flow network involving thousands of nodes (manufacturers, wholesalers, distributors, dispensers) and millions of product paths.

The Drug Supply Chain Security Act (DSCSA) mandates that by 2025, every package of prescription drugs must be traceable through this network. The challenge involves not just compliance, but scalability:

- Volume: Wholesalers like AmerisourceBergen handle over 275 million returned products annually.
- Complexity: Over 200 manufacturers and 3,000+ unique trading relationships.
- Latency tolerance: Verification must happen in seconds to avoid clogging warehouse workflows.

Traditionally, wholesalers would need to build direct point-to-point connections to every manufacturer.

- For 200 manufacturers × 50 wholesalers, that’s 10,000 direct integrations.
- Each integration requires its own data governance, security review, and SLA enforcement.
- In OR terms, this is an O(N²) scaling problem: the number of connections grows quadratically as participants increase.

This is unsustainable in both cost and operations. Even if one integration costs just $50,000 to build and maintain annually, the industry would spend $500 million every year on integrations alone.

From an operations research (OR) lens, this is a problem of distributed verification under high throughput constraints, where minimizing bottlenecks, optimizing routing, and preserving privacy are critical.

**Clearly, there is an inherent scalability challenge without blockchain.**

## MediLedger’s Use of Blockchain

MediLedger is a blockchain network created by Chronicled with big pharmaceutical companies, wholesalers, and regulators. Its main goal: help the U.S. drug supply chain meet Drug Supply Chain Security Act (DSCSA) rules, which aim to stop counterfeit drugs and improve traceability.

Instead of one company controlling the system, MediLedger uses a permissioned blockchain (Ethereum-based) where many trusted organizations run the network. To protect sensitive data, it relies on privacy tools like:

- Zero-knowledge proofs (ZKPs) → prove something is true without showing all the data.
- Hashed commitments (Merkle trees) → lock in data privately while still proving it hasn’t been tampered with.
- GS1 standards → make sure product IDs, barcodes, and events (like shipping/receiving) use a universal language.

Their biggest success? Proving that **drug returns** (where wholesalers check if a returned product is real before reselling it) can be verified **fast, securely, and without exposing private data.**

## The Legacy

Under DSCSA, every drug package must have a unique serial number. When a drug is returned to a wholesaler, the wholesaler must verify with the manufacturer that the serial number is still valid before putting it back on the shelf. Without blockchain, this would require *hundreds* of one-to-one connections between wholesalers and manufacturers. That’s slow, expensive, and hard to scale.

The industry solution? A Verification Router Service (VRS), like a postal service that automatically sends each query to the right manufacturer. MediLedger helped show that a VRS could run on blockchain while still keeping private data safe.

## Key Players

- Chronicled → built and runs the MediLedger network.
- Pharma manufacturers → Pfizer, Genentech, Gilead, etc.
- Wholesalers → McKesson, AmerisourceBergen, Cardinal Health.
- Regulators → FDA, NABP, HDA.
- Standards bodies → GS1 (barcodes, product IDs, event exchange).

## Summary of Outcomes

### FDA Pilot Success

The MediLedger pilot with the FDA showed that blockchain could handle large-scale drug verification securely. It proved that sensitive data could stay private while still being checked across many different computers. The system also worked well for verifying returned drugs and sharing product information.

### Industry Alignment on VRS

The Healthcare Distribution Alliance (HDA) created clear rules for the Verification Router Service (VRS), which lets wholesalers and manufacturers communicate about drug verification. Multiple providers—including MediLedger partners—tested these rules, showing that different systems could work together.

### Regulatory Adoption

The National Association of Boards of Pharmacy (NABP) now runs a system called Pulse, built on assets acquired from MediLedger’s Prescription Verification System. Regulators in 20 states and the DEA use it to monitor suspicious orders and verify drugs—evidence that blockchain-based tools are maturing and being used in real-world oversight.

## Architecture at a Glance

MediLedger’s architecture balances three competing priorities: regulatory compliance, commercial confidentiality, and interoperability. Its design goes beyond a simple permissioned ledger, combining blockchain consensus, cryptographic privacy tools, and standards-based integration layers. It is framed around the following core components:

- Blockchain Layer (Permissioned Ethereum) → trusted companies run validator nodes.
- On-chain vs Off-chain → only proofs and commitments go on-chain; actual business data stays private off-chain.
- Zero-Knowledge Proofs → confirm that a serial number is valid without showing sales data or pricing.
- Merkle Trees → secure off-chain data with cryptographic fingerprints stored on-chain.
- VRS + Look-Up Directory → wholesalers’ queries automatically routed to the right manufacturer.
- GS1 Standards → guarantee everyone uses the same product IDs and barcode formats.

## What Worked Well

MediLedger’s pilot and subsequent development revealed several successes that demonstrated the viability of blockchain in a heavily regulated, highly competitive industry. These achievements highlight why the project is considered one of the more mature examples of blockchain in healthcare and pharmaceuticals.

MediLedger worked well because it solved a real regulatory deadline, respected competitive business confidentiality, integrated with existing standards and systems, and established a neutral governance model. This combination allowed it to move beyond pilot hype into real-world adoption.

### FDA Pilot Results

- Demonstrated practical, privacy-preserving verification across 20+ companies at production scale.

### Regulatory Alignment and Industry Trust

- DSCSA Compliance: The MediLedger pilot successfully showed that blockchain could meet the 2019 DSCSA “saleable returns verification” requirements. Instead of relying on costly and error-prone point-to-point integrations, the network allowed wholesalers to verify product identifiers against manufacturer records quickly and reliably.
- FDA Engagement: The FDA was an active observer and later invited MediLedger to contribute to DSCSA 2023 interoperability pilots. This endorsement indicated regulators saw blockchain as a credible compliance tool, not a theoretical experiment.
- Industry Buy-In: Major companies such as Pfizer, Genentech, Gilead, AmerisourceBergen, and McKesson participated. The presence of large incumbents gave the network credibility and demonstrated willingness to collaborate across competitive lines.

### Preservation of Commercial Confidentiality

- Problem Addressed: Manufacturers feared revealing sensitive pricing, sales volumes, or distribution patterns.
- Solution: Zero-knowledge proofs and selective disclosure (via Merkle proofs) allowed verification of data without exposing the underlying details.
- Outcome: Participants were reassured that blockchain participation would not compromise trade secrets, a critical factor in securing adoption.

### Governance and Decentralization

- Model-based Distribution: MediLedger was deliberately designed as a permissioned consortium network, with governance distributed among participants rather than controlled by a single vendor.
- Outcome: Industry players felt comfortable joining, knowing no competitor or third-party vendor could monopolize the data.
- Lesson Learned: Decentralized governance is not just a technical issue, but a key trust factor in adoption.

### Technical Performance and Scalability

- Fast Verification: Wholesalers could verify a product identifier in near-real time (often under 2 seconds).
- Scalable Design: Because sensitive payloads remained off-chain, the blockchain layer stayed lean, supporting high transaction volumes without bloat.
- Reliability: Proofs stored on-chain were immutable, ensuring a clear audit trail for regulators.

### Strengthened Supply Chain Integrity

- Counterfeit Prevention: By making verification simple and tamper-proof, MediLedger helped reduce the risk of counterfeit or diverted drugs re-entering the supply chain.
- Audit Readiness: Regulators could independently verify compliance without accessing confidential transaction data.
- Market Impact: Wholesalers gained confidence that returned drugs were authentic, protecting patient safety and reducing waste.

### Strategic Success

- Cross-Industry Collaboration: MediLedger brought together competitors who rarely collaborate, showing blockchain’s ability to act as a “neutral ground.”
- Shift in Mindset: The pilot proved blockchain is not just hype, but a tool for solving practical compliance and interoperability challenges.
- Early Proof of Adoption: By 2020, MediLedger was not just a pilot but a functioning network with ongoing industry participation—rare in the blockchain healthcare landscape.

## Challenges Observed

One of the most significant challenges MediLedger encountered was **data quality**. In the pharmaceutical supply chain, Global Trade Item Numbers (GTINs) serve as critical identifiers for tracking and verifying products. However, during early pilots, mis-labeled or missing GTINs caused error rates as high as **5%**, undermining confidence in the system’s reliability. These errors were not necessarily due to blockchain itself but reflected broader inconsistencies in master data management across manufacturers, wholesalers, and distributors. Since blockchain systems depend on accurate inputs, poor data quality at the source often propagated throughout the network, requiring extensive cleanup before processes could stabilize.

Another obstacle involved **onboarding costs**, especially for mid-sized and smaller manufacturers. While large pharmaceutical companies often had the technical capacity and budgets to integrate blockchain solutions, many mid-tier organizations struggled with the expenses tied to IT upgrades, staff training, and compliance adjustments. This created uneven adoption across the supply chain, limiting the effectiveness of a network that relied on broad participation. The imbalance highlighted a common theme in distributed systems: the benefits of a shared platform increase only when a critical mass of participants adopt it, but those with fewer resources often lag behind.

Finally, the initiative faced challenges from **shifting regulatory timelines**. The FDA delayed enforcement of the Drug Supply Chain Security Act (DSCSA) several times, which created uncertainty for stakeholders. While some organizations pushed forward with blockchain pilots, others hesitated to commit resources until requirements were finalized. These delays stalled investment, slowed momentum, and made it harder for the MediLedger consortium to build and maintain alignment across participants. Regulatory ambiguity, in this sense, became a bottleneck as serious as technical or financial constraints.

## Takeaways

### Adopt Network-Based Designs

Healthcare supply chains are inherently large and fragmented, with hundreds of manufacturers, wholesalers, hospitals, and pharmacies interacting daily. A point-to-point integration model, where every participant connects individually with every other, quickly becomes unmanageable. For instance, even a relatively small network of 200 manufacturers and 50 wholesalers creates 10,000 integration paths to maintain. Blockchain-based, network-oriented architectures such as MediLedger’s Verification Router Service (VRS) reduce this burden by consolidating integrations into a shared hub-and-spoke system. This not only lowers the cost of implementation but also improves scalability, interoperability, and resilience.

### Plan for Hybrid Architectures

Healthcare generates vast amounts of data—from imaging files measured in gigabytes to longitudinal EHR records spanning decades. Storing such large files directly on-chain is both inefficient and impractical. A hybrid design is more sustainable: sensitive, large datasets remain off-chain in secure databases, while cryptographic proofs (such as hashes or Merkle roots) are recorded on-chain to provide immutability and traceability. This allows organizations to leverage blockchain’s security benefits without compromising system performance or inflating storage costs. For example, a genomic data repository might keep patient data off-chain but log integrity proofs on-chain, ensuring regulators or researchers can confirm authenticity without handling raw files.

### Build Key Recovery Systems

In a blockchain environment, access to data and permissions are tied to cryptographic keys. If those keys are lost, so is access to the associated data or capabilities—a catastrophic outcome in healthcare. Unlike financial systems, where a lost wallet might mean lost money, here it could mean the permanent loss of critical patient records. Healthcare applications must therefore incorporate user-friendly key recovery mechanisms, such as multi-signature wallets involving trusted custodians (e.g., the patient, provider, and a neutral recovery service) or biometric-based authentication layers. Without these safeguards, blockchain solutions will face adoption hurdles from both providers and patients.

### Model New Threats

Blockchain promises strong security, but it also introduces new vulnerabilities. On the cryptographic side, the rise of quantum computing could undermine widely used algorithms like RSA and elliptic-curve cryptography within the next few decades. Systems designed today should be adaptable to post-quantum standards to ensure long-term resilience. On the human side, blockchain does not eliminate risks such as phishing, credential theft, or social engineering. In fact, decentralization can make recovery harder if credentials are compromised. Effective blockchain adoption requires a proactive approach to modeling these emerging risks and building in mitigation strategies early, rather than retrofitting defenses after a breach.

### Pilot with Measurable Metrics

One of the strengths of operations research is its focus on measurable performance outcomes. Blockchain pilots in healthcare should be evaluated with clear metrics, such as latency (average query response under 1 second), throughput (transactions per hour), error rates (percentage of failed verifications), and cost savings (dollars saved per avoided rework or counterfeit interception). By quantifying outcomes, stakeholders can move beyond hype and evaluate whether blockchain is delivering operational value. For example, MediLedger demonstrated that returns verification could be performed at scale while saving wholesalers money through avoided inventory delays—proof that blockchain’s value can be measured in operational and financial terms.

## Things to Think About

### Could blockchain-enabled verification be extended beyond drugs—into medical devices or blood supply chains?

The DSCSA forced innovation in the pharmaceutical sector, but similar traceability and verification challenges exist elsewhere. Medical devices, for instance, have been subject to recalls due to counterfeit or defective parts. Blood and plasma products require strict chain-of-custody to maintain safety. Extending blockchain-based verification into these domains could address similar problems of trust, transparency, and counterfeit prevention. The scalability lessons learned from MediLedger could inform these adjacent sectors.

### How do we design patient-facing workflows that are as user-friendly as MediLedger’s wholesaler-facing system?

MediLedger focused primarily on B2B operations, where users were companies with IT departments. But healthcare blockchain adoption will eventually require patient-facing applications. This raises questions about usability: How do patients manage keys securely? How do they grant or revoke data access easily? How do they amend their records in compliance with HIPAA? The challenge is to make blockchain invisible to the end-user, embedding it in workflows that feel no more complex than today’s patient portals or mobile health apps.`
  },
  
{
  title: "Understanding ZK-SNARKs: The Cryptographic Foundation of Zero-Knowledge Rollups",
  date: "2025-09-09",
  slug: "understanding-zk-snarks-zero-knowledge-rollups",
  readTime: "6 min",
  tags: ["Blockchain", "Cryptography", "Ethereum"],
  content: `
Vitalik Buterin, co-founder of Ethereum, conceptualized the “blockchain trilemma” as the inherent challenge in achieving security, scalability, and decentralization simultaneously. Layer 2 (L2) protocols are designed to address the trilemma by enhancing scalability without compromising the security and decentralization that Layer 1 (L1) offers. Rollups bundle multiple transactions into a single batch to be processed off-chain on L2, thus significantly reducing the computational load and congestion on the L1 network.

Early Layer 2 solutions like Optimism and Arbitrum approached rollups optimistically, adopting an “innocent until proven guilty” mindset where transactions are valid unless challenged within a designated “challenge window.” Although computationally efficient, this centralized approach, where fraud detection is delegated to a limited number of “sequencers,” inherently introduces vulnerabilities. If actors fail in detection or collude, the system can be compromised. The challenge of maintaining decentralization while providing relatively inexpensive rollup is what motivates zero-knowledge rollups, the most pressing example of the power of zero-knowledge proofs on-chain. Maksym Petkus’ whitepaper, “Why and How zk-SNARK Works: Definitive Explanation”, demystifies ZK-SNARKs, the underlying mechanism behind ZK rollups, and the new wave of L2 solutions.

Among several approaches to implementing ZK rollups, ZK-SNARKs (Zero-Knowledge Succinct Non-Interactive Arguments of Knowledge) combine the best features–extremely small proof sizes and fast verification–while still maintaining strong security guarantees. The architecture relies on three essential properties: succinctness–proofs remain extremely small and quick to verify; non-interactivity–no need for multiple rounds of communication between the prover and verifier, thus helping with blockchain efficiency; and zero-knowledge–no additional information is given beyond the correctness of the statement being proven.

At a high level, ZK-SNARKs let a prover convince a verifier that they know a valid solution to a system of polynomial equations without revealing the solution itself. For example, the prover shows that a polynomial \`p(x)\` can be factored into a target polynomial \`t(x)\` and an arbitrary polynomial \`h(x)\` such that \`p(x) = t(x) ⋅ h(x)\`, without disclosing either polynomial. The verifier samples a random point \`r\`, the prover evaluates \`p(r)\` and \`h(r)\`, and the verifier checks that \`p(r) = t(r) ⋅ h(r)\`. If this holds, it suggests that \`p(x)\` has \`t(x)\` as a factor. On its own, this method is insecure: the prover could provide a different polynomial \`p'(x)\` that happens to satisfy the check at a chosen point. ZK-SNARKs remedy this by employing finite fields (Galois fields), wherein all operations are performed modulo a prime, preventing provers from exploiting large outputs to fake consistency. The homomorphic properties of polynomials, as explored later, mean that operations on the encoded modulo values reflect the same arithmetic operations done on the original, hidden values. This ensures the verifier can still validate the computations without accessing the underlying data and that a dishonest prover cannot alter the computation.

Some security concerns include falsifying polynomial factorizations, altering polynomial degrees or coefficients to satisfy verification checks, and manipulating intermediate operations in arithmetic circuits. To defend against these attacks, zk-SNARKs rely on the algebraic structure of polynomials and the cryptographic guarantees of group operations.

Specifically, the homomorphic properties of polynomials entail that operations performed on encoded values behave in-line with operations on the underlying values themselves. For example, if two values \`x\` and \`y\` are encoded as \`g^x\` and \`g^y\`, their product corresponds to \`g^(x+y)\`. This property ensures that manipulation of committed values still respects the original additive relationships. If there is a deviation, the verification fails. This is further reinforced by bilinear pairings, which confirm multiplicative relationships without revealing underlying values. A bilinear map \`g: G1 × G2 → GT\` satisfies the property \`g(aP, bQ) = g(P, Q)^(ab)\`, allowing the verifier to confirm multiplicative relationships between hidden values, checking whether two encoded elements multiply to a third without seeing the original, decoded numbers. Pairings tie together different parts of the proof, making it computationally infeasible to alter a component without damaging the consistency of the entire system.

Combining homomorphism with bilinear pairings, ZK-SNARKs enforce strong algebraic consistency checks through polynomials. These cryptographic tools ensure that a proof can only be generated with the correct computation, while keeping all underlying data hidden.

The security of ZK-SNARK relies on the trusted setup, where a Common Reference String (CRS) is generated to be used in proof creation and verification. If the underlying secret values (\`α\` and \`s\`) are not destroyed, the entity who retains them could forge false proofs, undermining the security of the entire system. To address this vulnerability, ZK-SNARK systems employ a multi-party CRS setup, often referred to as a ceremony. Instead of relying on a single entity, multiple independent participants contribute to the generation of the CRS. As long as at least one participant is honest and securely discards their secret contribution, the overall CRS remains trustworthy. By decentralizing responsibility and relying on random, unrelated participants, the risk of collusion is significantly reduced since verification steps ensure that no party can weaken the final parameters by using a weak choice of \`α\` or \`s\`.

Ultimately, ZK-SNARKs represent more than just a technical fix to blockchain’s scalability problem. ZKPs could underpin systems for digital identity, voting, or financial auditing, where sensitive information must remain private but validity must still be universally verifiable.

## Figures

[Rollup Workflow Diagram](https://saanvi-lavande.vercel.app/images/rollup-workflow-diagram.png)

*Fig. 1: This workflow diagram shows how Optimistic and ZK Rollups contrast. In Optimistic Rollups, users submit transactions that a Sequencer batches and posts to Layer 1, assuming validity unless challenged within a “challenge window.” This approach is computationally inexpensive but introduces fraud risk if Sequencers fail or collude. ZK-SNARK Rollup, in contrast, requires nodes to submit cryptographic proofs with each batch, allowing Layer 1 to verify correctness instantly without a challenge period. This approach is decentralized, unlike the optimistic approach, and allows for transactions to be processed more instantly, whereas the challenge window typically lasts around 1 week.*

[Polynomial Proof Diagram](https://saanvi-lavande.vercel.app/images/polynomial-proof-diagram.png)

*Fig. 2: The goal of a polynomial proof in ZK-SNARK is to convince a verifier that they know a solution to a polynomial equation without revealing the solution. The key polynomials are: p(x): the “statement” polynomial (encodes the computation), t(x): target polynomial (e.g., constraints you want verified), h(x): helper polynomial, such that p(x) = t(x) ⋅ h(x)*
`
},

]
